Related references
Note: Only part of the references are listed.Ibrutinib and Venetoclax for First-Line Treatment of CLL
Nitin Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
E. I. Andersson et al.
LEUKEMIA (2018)
Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients
Liye He et al.
CANCER RESEARCH (2018)
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures
Julie Dyall et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Combine and conquer: challenges for targeted therapy combinations in early phase trials
Juanita S. Lopez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
Tracy Murphy et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Connie Lee Batlevi et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data
Aleksandr Ianevski et al.
BIOINFORMATICS (2017)
Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma
Sophia Gayle et al.
BLOOD (2017)
Combenefit: an interactive platform for the analysis and visualization of drug combinations
Giovanni Y. Di Veroli et al.
BIOINFORMATICS (2016)
Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells
Prson Gautam et al.
MOLECULAR CANCER (2016)
Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
Thomas J. Hwang et al.
JAMA INTERNAL MEDICINE (2016)
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity
Lisa M. Johansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model
Bhagwan Yadav et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
A Correlation Between the In Vitro Drug Toxicity of Drugs to Cell Lines That Express Human P450s and Their Propensity to Cause Liver Injury in Humans
Frida Gustafsson et al.
TOXICOLOGICAL SCIENCES (2014)
Synergistic Drug Combinations for Tuberculosis Therapy Identified by a Novel High-Throughput Screen
Santiago Ramon-Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phase II failures: 2008-2010
John Arrowsmith
NATURE REVIEWS DRUG DISCOVERY (2011)
Colchicine poisoning: the dark side of an ancient drug
Yaron Finkelstein et al.
CLINICAL TOXICOLOGY (2010)
Share Paper
